Votes: IL HB4055 | 2023-2024 | 103rd General Assembly
Bill Title: Amends the Prior Authorization Reform Act. Provides that notwithstanding any other provision of law, a health insurance issuer or a contracted utilization review organization may not require a prior authorization for drug therapies approved by the U.S. Food and Drug Administration for the treatment of hereditary bleeding disorders any more frequently than 6 months or the length of time the prescription for that dosage remains valid, whichever period is shorter. Effective January 1, 2026.
Spectrum: Moderate Partisan Bill (Republican 9-1)
Status: (Enrolled) 2024-05-15 - Passed Both Houses [HB4055 Detail]
Text: Latest bill text (Enrolled) [HTML]
States not producing parsable votes may be available as images in Supplemental Documents.
Spectrum: Moderate Partisan Bill (Republican 9-1)
Status: (Enrolled) 2024-05-15 - Passed Both Houses [HB4055 Detail]
Text: Latest bill text (Enrolled) [HTML]
Voting Records
Chamber | Vote | Date | Yea | Nay | NV | Abs | Total | Result | Source | View |
---|---|---|---|---|---|---|---|---|---|---|
No roll call record information currently on file. |